Therefore, while we must be cautious in how we interpret this data, our approach validates the importance of PPARɣ and additionally shows a direct impact of GATA3 and FOXA1 on the expression of markers of the luminal molecular subtype of bladder cancer. The gene discussed is GATA3; the disease is urinary bladder cancer.